Anti-Infective Position

[anonymous]

So still no news? Nothing?

 

[anonymous]

They are still recruiting for positions and letting it be known that for the last year there has been talk of the division being sold, they just don’t know when. But they want to continue business as usual until something happens. The uncertainty.

 

[anonymous]

No buyers. No buyers for any of the antibiotic start ups either. So much needless chaos, drama, turnover, and grief with the unprofessional way Allergan has batted this division around. Such a shame.

 

[anonymous]

It is a shame. We have the best anti-infective portfolio in the industry and are profitable. Leave well alone

 

[anonymous]

It is a shame. We have the best anti-infective portfolio in the industry and are profitable. Leave well alone

Deal is done. Stay tuned...

 

[anonymous]

Deal is done. Stay tuned...

Hello Nabriva!

 

[anonymous]

How long will it take? Interviewing for another position outside the company.

 

[anonymous]

How long will it take? Interviewing for another position outside the company.

Good luck with your Achaogen interviews

 

[anonymous]

Hello Nabriva!

Nabriva?!!! Get ready for sample attainment quotas and logging calls into veeva.

 

[anonymous]

Nabriva?!!! Get ready for sample attainment quotas and logging calls into veeva.

We already do that

 

[anonymous]

Achaeogen. Haha. That house of cards won't make it through the end of the quarter. Nabriva is an interesting possibility -- they are the only ones who don't have the Forest rejects currently running things.

 

[anonymous]

So who will it be?

 

[anonymous]

So who will it be?

No deal. The person who posted that was just trying to get everyone excited.

 

[anonymous]

We will be sold

 

[anonymous]

We will be sold

Thanks, Captain Obvious. Just like Christmas is every year on Dec 25.

 

[anonymous]

Nabriva?!!! Get ready for sample attainment quotas and logging calls into veeva.

It won't be Nabriva. They are actively pursuing our Salesforce for the potential launch of their own products

 

[anonymous]

It won't be Nabriva. They are actively pursuing our Salesforce for the potential launch of their own products

Here’s another Captain Obvious. They have reached out to any and every rep with anti-infective experience!

 

[anonymous]

Here’s another Captain Obvious. They have reached out to any and every rep with anti-infective experience!

Got an email from a recruiter about the Nabriva gig- no specifics though. While this place continues to be a slow motion train wreck, I look at what's going down with Mylenta and Archageon as examples of what not to do. Despite the morons up top and the travesty that has become the AI experience of Allergan I'm going to ride it out because at least our drugs are solid.

 

[anonymous]

Here’s another Captain Obvious. They have reached out to any and every rep with anti-infective experience!

This douche seems to have all of the answers. Please enlighten us with all of your infinite wisdom. Yes, they have reached out, so thanks for validating that and offering no independent thought of your own...

 

[anonymous]

OK!

So what's the vote:

Nabriva
Achaeogen
Shinogi


Or.....none of the above?

P.S. The Durata folks must still be laughing themselves silly still, all the way to the bank as to how they snookered Saunders for 697 million. Geez.